Security key
500946108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 14,425,902
- Total 13F value
- $190,125,640
- Share change
- +1,609,761
- Put/Call ratio
- 31%
- SEC-reported price per share
- $13.18
- Number of holders
- 106
- Value change
- +$21,488,354
- Number of buys
- 63
- Number of sells
- 30
- Shares outstanding
- 14,420,955
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
106
Top holders
10
KRRO full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q3 2025
Korro Bio, Inc. SEC filings
Korro Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 500946108
Recent filing periods:
Ownership snapshot
Top reported holders of KRRO - Korro Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: Lynx1 Capital Management LP
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
11%
Venrock Healthcare Capital Partne...
9.9%
New Enterprise Associates 17, L.P.
9.9%
BALYASNY ASSET MANAGEMENT L.P.
6.6%
Nantahala Capital Management, LLC
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13D/G
13F
Company
|
11%
|
$18,351,871
1,538,296 shares
|
+$9,599,630 | 31 Mar 2026 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
9.9%
|
$17,760,012
1,488,685 shares
|
$0 | 10 Mar 2026 |
| New Enterprise Associates 17, L.P. |
13D/G
3/4/5
Ali Behbahani · 10%+ Owner
|
9.9%
|
$17,130,522
1,456,677 shares
|
$0 | 10 Mar 2026 |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
13F
Company
|
6.6%
|
$13,857,960
951,783 shares
|
$0 | 30 Jun 2026 |
| Nantahala Capital Management, LLC |
13F
13D/G
Company
|
6.4%
from 13D/G
|
$7,471,608
660,036 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
5.2%
|
$9,853,180
747,546 shares
|
$0 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
106
Shares
14,425,902
Rows available
106
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q3 2025 Across Filers
Q3 2025 holders
90
Q2 2026 holders
106
Holder diff
16
| Investor | Q3 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend